Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Cardiff Oncology Inc (CRDF)

Cardiff Oncology Inc (CRDF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Rising Number of Studies to Develop Novel Therapies For Pancreatic Ductal Adenocarcinoma (PDAC) Intensely Increasing FinancialNewsMedia - Mon Oct 23, 2023

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:CRDF),(NYSE:LLY),(NYSE:ABBV),(NASDAQ:LIPO) EQNX::TICKER_END

ONCY : 1.0600 (+2.91%)
ONC.TO : 1.44 (+0.70%)
CRDF : 4.35 (-0.46%)
LLY : 726.31 (-2.63%)
ABBV : 166.41 (+1.06%)
LIPO : 0.7179 (+0.64%)
Wall Street - Nasdaq Times Square
Nasdaq Futures Climb as Bond Yields Retreat From Decade Highs, Micron Earnings on Tap Barchart - Wed Sep 27, 2023

December Nasdaq 100 E-Mini futures (NQZ23) are trending up +0.44% this morning as U.S. Treasury yields slipped from decade highs, while investors braced for a new round of economic data as well as an earnings...

NQZ23 : 16,530.23s (-0.07%)
CTAS : 661.29 (-0.17%)
AAPL : 165.00 (-1.22%)
GOOGL : 154.09 (-1.23%)
AMZN : 174.63 (-2.56%)
DKNG : 40.68 (-2.31%)
MU : 106.77 (-4.61%)
PAYX : 119.52 (+1.47%)
JEF : 42.17 (+1.57%)
HMB.S.DX : 171.100 (+0.03%)
COST : 709.51 (-0.24%)
CHPT : 1.3600 (-1.45%)
Cardiff Oncology Announces Positive Clinical Data in Pancreatic Cancer and Small Cell Lung Cancer, including Single-Agent Activity from Onvansertib Monotherapy PR Newswire - Tue Sep 26, 2023

Pancreatic Cancer Program - Pancreatic cancer Phase 2 trial of onvansertib + SoC in the second-line setting demonstrated greater efficacy vs. historical...

CRDF : 4.35 (-0.46%)
Cardiff Oncology to Present at Upcoming Investor Conferences in September PR Newswire - Tue Sep 5, 2023

/PRNewswire/ -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug...

CRDF : 4.35 (-0.46%)
Cardiff Oncology Reports Second Quarter 2023 Results and Provides Business Update PR Newswire - Wed Aug 9, 2023

/PRNewswire/ -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug...

CRDF : 4.35 (-0.46%)
Biotech Market Update: Global Pharmaceuticals Market Expected to Reach $1.5 Trillion by Year’s End FinancialNewsMedia - Wed Aug 9, 2023

EQNX::TICKER_START (NYSE:PTN),(NASDAQ:CRDF),(NASDAQ:BDRX),(NASDAQ:DRUG),(NYSE:LLY) EQNX::TICKER_END

CRDF : 4.35 (-0.46%)
BDRX : 0.7520 (-8.30%)
DRUG : 1.1200 (-5.08%)
LLY : 726.31 (-2.63%)
PTN : 1.8400 (-2.65%)
Biotech Market Update: Global Pharmaceuticals Market Expected to Reach $1.5 Trillion by Year's End PR Newswire - Wed Aug 9, 2023

/PRNewswire/ -- About 9.4% of the world population is aged 65 or above. Older people typically consume more medicines than the people in other age group...

PTN : 1.8400 (-2.65%)
CRDF : 4.35 (-0.46%)
BDRX : 0.7520 (-8.30%)
DRUG : 1.1200 (-5.08%)
LLY : 726.31 (-2.63%)
Cardiff Oncology Announces New Lead Program in First-Line Metastatic Colorectal Cancer and Expanded Pfizer Relationship PR Newswire - Mon Aug 7, 2023

- Advance to first-line RAS-mutated mCRC follows the strong signal from new clinical and preclinical data, and agreement with FDA - - First-line mCRC...

CRDF : 4.35 (-0.46%)
Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) PR Newswire - Mon Jul 24, 2023

/PRNewswire/ -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug...

CRDF : 4.35 (-0.46%)
Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) PR Newswire - Tue Jun 20, 2023

/PRNewswire/ -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug...

CRDF : 4.35 (-0.46%)

Barchart Exclusives

Up 67% YTD, Is Soundhound AI Overvalued? Barchart - 1 hour ago
Soundhound AI's shares have surged, thanks to Nvidia's investment in the company and growing enthusiasm surrounding AI. After a steep pullback, is the stock still overvalued? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot